Dr. Maged A. Amine, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 40
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,192
Licensed in Texas since 1996, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
TX license K1340 (first issued 1996; active) -
Cardiovascular Disease Physician
TX license K1340 (first issued 1996; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Houston Methodist Hospital Houston, TX
- Houston Methodist the Woodlands Hospital The Woodlands, TX
- Houston Methodist Willowbrook Hospital Houston, TX
- Houston Methodist Cypress Hospital Cypress, TX
Medical groups
- Tmh Physician Associates PLLC (1,690 clinicians)
- Houston Methodist Specialty Physicians (1,528 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,192
- Services billed
- 4,788
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 863 | 484 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 680 | 541 |
| Injection, regadenoson, 0.1 mg | 456 | 114 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 443 | 396 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 360 | 355 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 268 | 134 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 169 | 166 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 166 | 166 |
| New patient office or other outpatient visit, 45-59 minutes | 142 | 142 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 96 | 32 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Rosuvastatin Calcium Other prescribers in Houston, TX | 421 |
| Losartan Potassium Other prescribers in Houston, TX | 361 |
| Amlodipine Besylate Other prescribers in Houston, TX | 353 |
| Eliquis (apixaban) Other prescribers in Houston, TX | 311 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Houston, TX | 279 |
| Atorvastatin Calcium Other prescribers in Houston, TX | 243 |
| Amiodarone Hcl Other prescribers in Houston, TX | 221 |
| Olmesartan Medoxomil Other prescribers in Houston, TX | 213 |
| Entresto (sacubitril/valsartan) Other prescribers in Houston, TX | 210 |
| Lisinopril Other prescribers in Houston, TX | 206 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 25 companies reported 118 payments worth $5,333 in total to this clinician.
| Cagent Vascular Inc | $2,589 |
|---|---|
| Abbott Laboratories | $474 |
| Alnylam Pharmaceuticals Inc. | $210 |
| Novartis Pharmaceuticals Corporation | $200 |
| E.r. Squibb & Sons, L.l.c. | $193 |
| Shockwave Medical, Inc | $172 |
| Medtronic, Inc. | $170 |
| Pfizer Inc. | $161 |
| Food and Beverage | $3,257 |
|---|---|
| Travel and Lodging | $2,064 |
| Entertainment | $11.96 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Cagent Vascular Inc Apr 16, 2025 | Travel and Lodging Serrantor · PNO · travel to NAPA, CA | $1,144 |
| Cagent Vascular Inc Mar 21, 2025 | Travel and Lodging Serrantor · PNO · travel to San Francisco, CA | $493 |
| Cagent Vascular Inc Apr 24, 2025 | Travel and Lodging Serrantor · PNO · travel to Palo Alto, CA | $427 |
| Argentum Medical Nov 17, 2025 | Entertainment | $11.96 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.